New drugs, new problems

Australian Journal of Forensic Sciences

Volumn 37, Issue 1, 2005, Pages 9-25

  Lucire, Yolande ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; LOFEPRAMINE; MIANSERIN; NEFAZODONE; NEW DRUG; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; ROFECOXIB; SEROTONIN UPTAKE INHIBITOR; SERTINDOLE; SERTRALINE; TRAZODONE; VENLAFAXINE; ZIPRASIDONE;

AGGRESSION; DEPRESSION; DISASTER; HUMAN; MORTALITY; PUBLIC HEALTH; REVIEW; SUICIDE; VIOLENCE;

EID: 23044471478     PISSN: 00450618     EISSN: 1834562X     Source Type: Journal    
DOI: 10.1080/00450610509410608     Document Type: Article

References (53)

1. Lazarou J, Pomeranz BH and Corey PN: Incidence of adverse drug reactions in hospitalised patients: a meta-analysis of prospective studies. JAMA, 279:1200-1205, 1998.
2. Total Recall. Four Comers. ABC. 10 April 2005 on Vioxx.
3. Press Release: Office of Elliot Spitzer May 13, 2004 http://www.oag.state.nv.us/press/2004/rnav/rnavl3h04.html
4. Schulte J: Homicide and suicide associated with akathisia and haloperidol. American Journal of Forensic Psychiatry; 6:3-7, 1985.
5. Shear MK: Suicide associated with akathisia and depot fluphenazine treatment. Journal of Clinical Psychopharmacology, 3:235-236, 1983.
6. Sachdev P: Akathisia and Restless Legs. Cambridge University Press, 1996.
7. Whittaker Robert: Mad In America. Perseus Publishing, 2002.
8. Schulte J: Homicide and suicide associated with akathisia and haloperidol. American Journal of Forensic Psychiatry, 6:3-7, 1985.
9. Whittaker Robert. Mad In America. Perseus Publishing, 2002.
10. Teicher M, Glod C and Cole J: Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry, 147:207-210, 1990.
11. Zoloft Defence Manual obtained lawfully from Messrs Pfizer Inc. by way of a web cast from Court T.V. located at http:/Avww.courttvxom/trials/pitlman/docs/?oloftmanual.html described as "Pfizer's Zoloft Litigation Manual" and an exhibit from the Christopher Pittman double murder trial, no longer accessible.
12. William Daubert, et ux., etc., et al., Petitioners v. Merrell Dow Pharmaceuticals, Inc. Supreme Court of the USA, June 28, 1993.
13. Healy D: Let them Eat Prozac. New York University Press, 1994 et sequii, 1993.
14. Muijen M. et al.: A comparative clinical trial of fluoxetine, mianserin, and placebo in depressed outpatients, Acta Psychiatrica Scandinavica, 78:384-390, 1988.
15. Jick H, Kaye JA and Jick SS: Antidepressants and the risk of suicidal behaviors. JAMA 292: (3), 338-343, 2004a.
16. Jick S, Dean AD and Jick H: Antidepressants and suicide. BMJt 310:215-8, 1995.
17. Kirsch I, Moore TJ et al: The emperor's new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration. Prevention and Treatment 5: Article 23, Posted 15 Jul 2002. http://www.ioumals.apa.org/prevention/volume5/pre0050023n.html
18. Boardman AP and Healy D: Modeling suicide risk in primary care primary affective disorders. Eur Psychiatry 16:400-405, 2001.
19. Donovan S, Kelleher MJ et al: The occurrence of suicide following the prescription of antidepressant drugs. Archives of Suicide Research, 5:181-192, 1999.
20. Donovan S, Clayton, A et al: Deliberate self-harm and antidepressant drugs. Investigation of a possible link. British Journal of Psychiatry, 177; 551-556, 2000.
21. Khan A, Khan, SR et al: Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database. American Journal of Psychiatry; 158:1449-1454, 2001a.
22. Khan A, Warner HA and Brown WA: Symptom reduction and suicide risk in patients treated with placebo in anti-depressant clinical trials: An analysis of the Food and Drug Administration database. Archives of General Psychiatry, 57:311-317, 2000.
23. Healy D and Whitaker C: Antidepressants and suicide: risk-beneFit conundrums. Journal of Psychiatry & Neuroscience, 28:331-337, 2003a.
24. Healy D: Let them Eat Prozac. New York University Press, 2003.
25. Healy D: Shaping the intimate: influences on the experience of everyday nerves. Social Studies of Science 34:239-245, 2004.
26. Harris G: Popular drugs for dementia tied to deaths. The New York Times, April 12, 2005.
27. Geddes J: Atypical antipsychotics in the treatment of schizophrenia: a systematic overview and meta-regression analysis BMJ 321:1371-1376, 2000.
28. Whittaker Robert: Mad In America. Perseus Publishing, 2002.
29. Harris G: Popular drugs for dementia tied to deaths. The New York Times, April 12, 2005.
30. FDA Public Health Advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances: http://www.fda.gov/cder/drug/advisorv/antipsvchotics.htm
31. Meltzer HY et al: Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial [see comment][erratum appears in Arch Gen Psychiatry, 60:735, 2003]. Archives of General Psychiatry; 60:82-91, 2003.
32. Details from Professor C. Adams of the Cochrane Centre for Schizophrenia, Leeds, October 2004. Cited by David Healy.
33. Merson J: Epistemic Capture: The Science and Politics of Stress-related Illness. PhD thesis UNSW 2004.
34. Tanaka E and Hisawa S: Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system. Journal of Clinical Pharmacy & Therapeutics, 24:7-16, 1999.
35. Preda A, MacLean RW et al.: Antidepressant-associated mania and psychosis resulting in psychiatric admissions. Journal of Clinical Psychiatry, 62:30-33, 2001.
36. Greenland H: Dying shame. The Bulletin, 3 October 2003.
37. Tracking Tragedy (2003) the Report of the Sentinel Events Committee http://pandora.nla.gov.au/nla.arc-40156.
38. Report of the New South Wales Chief Health Officer 2003-4, Separations for Suicide Attempts http://www.health.nsw.gov.au/public-health/chorep/men/mensuihostable.htm#table
39. Coglan R, Lawrence D et al: Duty to Care:Physical Illness in People with Mental Illness: Department of Public Health and Department of Psychiatry and Behavioral Science, University of Western Australia.
40. Drew L: Mortality and mental illness. Australian and New Zealand Journal of Psychiatry, 39:194-197, 2005.
41. Kalucy R, Thomas D and King D: Changing demand for mental health services. Australian and New Zealand Journal of Psychiatry. 30:74-80, 2005.
42. Hacker S and Madden R: Mental Health Services in Australia (5) 2001-2002. Australian Institute of Health and Welfare, Canberra, 2004.
43. House of Commons Health Committee: The Influence of the Pharmaceutical Industry Fourth Report of Session 2004-05 Volume 1, London.
44. Hundreds of sites, legal transcripts, judgements and medical papers can be found by searching SSRI homicide, SSRI suicide, SSRI litigation on google.com.
45. The Queen v. Falconer (1990) 171 CLR 30 F.C. 90/045.
46. FDA Public Health Advisory March 22, 2004 Subject: Worsening Depression and Suicidality in Patients Being Treated with Antidepressant Medications http://www.fdn.gov/cder/drug/antidepressants/AntidepressanstPHA.htm
47. Angell M: The Truth about Drug Companies. Random House, 2004. Op Ed, The Boston Globe, March 10, 2005.
48. Yallop R: Suicide warning urged for Prozac, The Australian March 25, 2004.
49. Editorial: The New York Tunes. 6 December 2004
50. The New York Times March 10, 2005.
51. The Los Angeles Times, March 10, 2005.
52. Hassner Sharav, Vera: Alliance For Human Research Protection (AHRP) website at veracare@ahrp.org provides a running commentary and international press reports on drug safety scandals emerging daily at the FDA.
53. Anonymous: Critical condition, The Age, Melbourne, 17 March 2004.